Coronavirus in Houston — Report From the Front Lines
Coronavirus in Houston — Report From the Front Lines
Kalpalatha K. Guntupalli, MD of Baylor College of Medicine discusses the surge and ICU management of COVID-19 patients in Houston, Texas. Recorded on July 10, 2020. A better quality version of this interview has been uploaded to our website: https://edhub.ama-assn.org/jn-learning/video-player/18524545Topics discussed in this interview:
0:00 Introduction
1:09 What is your ICU in Houston like right now?
2:52 The availability of testing
4:36 How are the health care workers in your ICU doing?
6:19 Are you seeing younger or older patients in your ICU?
7:21 COVID-19 treatments and therapies
9:20 Proning patients
11:23 Length of stay in the ICU for COVID-19 patients
11:55 Protocols for proning and proning teams
13:36 What's unique about this pandemic?
16:08 Masks
18:00 Testing
18:30 Length of recovery and long-term morbidity
19:53 Off-label use of heparin and inhaled budesonide
21:25 Clinical observations of COVID-19 patients
23:52 What worries you the most right now?
28:36 What do you think the next few weeks will look like in Houston?
• Earn Free CME credits by watching JAMA Livestreams and completing a brief questionnaire. Claim 0.5 credits for each video at https://ja.ma/covidqa
• Coronavirus Resource page from the JAMA Network: https://ja.ma/covidyt
=====================================================================
To watch all the #JAMALive Q&A's Visit: https://ja.ma/covidqaytpl
Don't forget to hit subscribe or click https://ja.ma/subscribe
#COVID19 #Coronavirus #SARSCoV2
---------------------------------------------------------------------------------
For more from JAMA
• https://www.jama.com
• https://www.facebook.com/JAMAJournal
• https://www.twitter.com/JAMA_Current
• https://www.linkedin.com/company/jamanetwork
Follow the #JAMANetwork
• https://www.jamanetwork.com
• http://www.jamanetworkaudio.com
• https://www.facebook.com/JAMANetwork
• https://www.twitter.com/JAMANetwork
• https://www.instagram.com/JAMANetwork
• https://www.pinterest.com/JAMANetwork
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.